Alkermes Plc (ALKS)
0 followers · Follow
| Sector: | HEALTH CARE |
| Industry: | PHARMACEUTICALS |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Richard F. Pops |
| Employees: | 2,280 |
| Web site: | alkermes.com |
| CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, L2, 00000 00-353-1-772-8000 | |
| Date | Ratio |
|---|---|
| 2000-05-15 | 2:1 |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Alkermes plc researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; VIVITROL, and VUMERITY. The company is also developing LYBALVI, an oral atypical antipsychotic drug candidate.
Please log in first to see chart